Skip to content

Clinical trials

Hypertension trials in Croatia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension Country / region: Croatia Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20072
20081
20111
20141
20172
20183
20192
20212
20222
20242
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Not yet recruiting4
Terminated3
Recruiting2
Unknown status2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Josip Juraj Strossmayer University of Osijek4
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2
Relypsa, Inc.2
United Therapeutics2
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA1
Bayer1
Boehringer Ingelheim1
CSL Behring1
Clinical Hospital Centre Zagreb1
Dr. Josip Benčević General Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension25
Cardiovascular Diseases4
Renal Insufficiency, Chronic4
Diabetes Mellitus, Type 23
Essential Hypertension3
Pulmonary Arterial Hypertension3
Connective Tissue Diseases2
Diabetes Mellitus2
Familial Primary Pulmonary Hypertension2
Heart Failure2

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.